About
Parastoo Khoshakhlagh, Ph.D., is a biotech entrepreneur and scientist who serves as CEO and co-founder of GC Therapeutics, a Cambridge-based cell-therapy company built on technology she co-invented during postdoctoral research in George Church's lab at Harvard Medical School. She previously completed postdoctoral work at the Harvard-MIT Division of Health Sciences and Technology, co-founded Tympanogen, and contributed IP tied to Axosim. Public sources also place her on the boards of Tympanogen and Boston Ballet, and on MassBio's board of directors.
Areas of interest
biotechcell therapyregenerative medicinesynthetic biologystem cellsmachine learning in drug discoverydrug discoveryspace medicinetissue regenerationmedical deviceshearing repair